A significant discovery in cancer investigation is arising with the use of nanobodies to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently inactivated in many types of cancer, https://wavesocialmedia.com/story7693372/nanobodies-revive-p53-a-potential-hope-for-cancer-therapy